#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Orthostatic hypotension Prader-Willi syndrome Metastases to peritoneum Pemphigoid Haemolytic uraemic syndrome Von Hippel-Lindau disease Carcinoid tumour Neuroendocrine carcinoma Acute respiratory distress syndrome Anal fistula Neuroblastoma Cholangitis sclerosing Juvenile psoriatic arthritis Idiopathic intracranial hypertension Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Trials in Disease Combined immunodeficiency Mantle cell lymphoma refractory Primary immunodeficiency syndrome – Life with Disease Loeys-Dietz syndrome – Trials in Disease Pulmonary fibrosis – Treatment Fragile X syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Hairy cell leukaemia recurrent Alagille syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trametinib Prasinezumab SELTOREXANT Jnj-77242113 Nilotinib Water For Injection Pomalidomide Trastuzumab Emtansine Raltegravir Lovo-B ALE1 Eik1003 Transpocart19 Tabelecleucel Acasunlimab Dalteparin Sodium Digoxin Immune Fab (Ovine) Ranolazine Rhh646 Levothyroxine More therapies…

    Learn about Your Condition

    Epstein-Barr virus infection Abortion threatened Laryngeal cancer stage III Ventricular tachycardia Angina pectoris HER2 positive gastric cancer Endocrine disorder Dysmenorrhoea Thymic carcinoma Urinary incontinence Cortical dysplasia Triple negative breast cancer Acute myeloid leukaemia Renal transplant Neuromyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Belantamab Mafodotin
    • Bortezomib
    Belgium Czechia France Germany Greece Italy +3

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    • Zanidatamab
    Belgium France Germany Italy Spain

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Salbutamol
    • Glycopyrronium Bromide
    • Budesonide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Thrombocytopenia
    Investigated Drugs:
    • Netupitant
    • Pacritinib
    • Aprepitant
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Andersen-Tawil syndrome
    • Arrhythmia
    Investigated Drugs:
    • Atenolol
    • Bisoprolol Fumarate
    • Chlortalidone
    The Netherlands

  • Study on ER004 for Treating Boys with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Congenital ectodermal dysplasia
    Investigated Drugs:
    • Human Immunoglobulin G1 Constant Region – Human Ectodysplasin-A1 Receptor-Binding Domain Fusion Protein
    France Germany Italy Spain
Previous Page
1 … 499 500 501 502 503 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!